🇨🇦🏥🥷 Profile picture
Talking favourite things: cancer medicine, healthcare finance, portfolio management, tech & gaming. Nerd. Reviewer 2.
Jan 3, 2019 17 tweets 11 min read
I will now proceed to go on a #tweetrant / #tweetorial with regards to #Pharmaceutical #biotech pricing (focus on #cancer).

Very timely, also see @WSJ wsj.com/articles/big-p… on price hikes.

For the record, no #COI / #FCOI. Feel free to contribute to this discussion. Lets look at the problem from the @PhRMA / business perspective. And lets suppose you are a wonderful company, started by wonderful people who just want to make the world a better place (I know, not real, but stay with me for a minute).